Our recent studies show that cultured human CCA cells treated with LIF are protected from apoptosis induced by gemcitabine and cisplatin, an effect mediated by a STAT3- and MAPK-independent, PI3K/Akt-dependent Mcl-1 upregulation. The gene discussed is MCL1; the disease is cholangiocarcinoma.